Cytogenetic anaysis of a benzypyrene induced osteosarcoma in the rat (Rattus norvegicus)SCHMIDT, H; RATH, F.-W.Cancer genetics and cytogenetics. 1993, Vol 71, Num 2, pp 139-143, issn 0165-4608Article

G2/M checkpoint is p53-dependent and independent after irradiation in five human sarcoma cell linesBACHE, M; DUNST, J; WÜRL, P et al.Anticancer research. 1999, Vol 19, Num 3A, pp 1827-1832, issn 0250-7005Article

Pattern of lymph node metastases in papillary thyroid carcinomaGIMM, O; RATH, F. W; DRALLE, H et al.British journal of surgery. 1998, Vol 85, Num 2, pp 252-254, issn 0007-1323Article

The p53 gene in soft tissue sarcomas : Prognostic value of DNA sequencing versus immunohistochemistryTAUBERT, H; WÜRL, P; BACHE, M et al.Anticancer research. 1998, Vol 18, Num 1A, pp 183-187, issn 0250-7005Article

Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53BACHE, M; PIGORSCH, S; DUNST, J et al.International journal of cancer. 2001, Vol 96, Num 2, pp 110-117, issn 0020-7136Article

Cerebral heterotopia appearing as an extranasal polypTAEGE, C; MUSIL, A; KLOHS, G et al.European journal of pediatric surgery. 2001, Vol 11, Num 4, pp 268-270, issn 0939-7248Article

Influence of high density lipoprotein (HDL), prepared from human blood, on prostanoid formation, serum and tissue lipids and development of arteriosclerosis in cholesterol rich fed rabbitsBEITZ, J; KUKLINSKI, B; BEITZ, A et al.Prostaglandins, leukotrienes and essential fatty acids. 1990, Vol 40, Num 3, pp 211-215, issn 0952-3278Article

The influence of zinc administration on the development of experimental lung metastases after an injection of tumour cell into the tail vein of ratsRATH, F.-W; KÖRTGE, R; HAASE, P et al.Experimental pathology (1981). 1991, Vol 41, Num 4, pp 215-217, issn 0232-1513Article

Lepra : dimorphe Variante = Dimorphous variant of leprosyKNOLLE, J; PONTIKOS, S; RATH, F.-W et al.Zentralblatt für Pathologie. 1991, Vol 137, Num 5, pp 443-447, issn 0863-4106Article

Significance of proliferative activity and DNA ploidy in pancreatic cancer and chronic pancreatitisLOERTZER, H; HINZE, R; KNOLLE, J et al.International journal of pancreatology. 1999, Vol 26, Num 2, pp 77-83, issn 0169-4197Conference Paper

Primary hereditary medullary thyroid carcinoma : C-cell morphology and correlation with preoperative calcitonin levelsHINZE, R; HOLZHAUSEN, H.-J; GIMM, O et al.Virchows Archiv. 1998, Vol 433, Num 3, pp 203-208, issn 0945-6317Article

Molecular characterization and liposomal transfection of a p53-mutated cell line established from a poorly differentiated leiomyosarcomaMEYE, A; BACHE, M; HINZE, R et al.International journal of oncology. 1998, Vol 13, Num 2, pp 241-248, issn 1019-6439Article

Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevanceWÜRL, P; WEIGMANN, F; MEYE, A et al.Scandinavian journal of gastroenterology. 1997, Vol 32, Num 11, pp 1147-1151, issn 0036-5521Article

Cytogenetic characterization of ten malignant fibrous histiocytomasSCHMIDT, H; KÖRBER, S; HINZE, R et al.Cancer genetics and cytogenetics. 1998, Vol 100, Num 2, pp 134-142, issn 0165-4608Article

Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma : identification of seven new mutations for soft tissue sarcomasTAUBERT, H; WÜRL, P; MEYE, A et al.Cancer. 1995, Vol 76, Num 7, pp 1187-1196, issn 0008-543XArticle

A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular dataWÜRL, P; LAUTENSCHLÄGER, C; MEYE, A et al.Anticancer research. 2000, Vol 20, Num 3B, pp 2065-2072, issn 0250-7005Article

No p16^INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomasMEYE, A; WÜRL, P; HINZE, R et al.Journal of pathology. 1998, Vol 184, Num 1, pp 14-17, issn 0022-3417Article

p53 status in radiation-induced soft-tissue sarcomasTAUBERT, H; MEYE, A; BACHE, M et al.Strahlentherapie und Onkologie. 1998, Vol 174, Num 8, pp 427-430, issn 0179-7158Article

Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomasWÜRL, P; MEYE, A; LAUTENSCHLÄGER, C et al.Cancer letters. 1999, Vol 139, Num 2, pp 159-165, issn 0304-3835Article

High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremitiesWÜRL, P; MEYE, A; SCHMIDT, H et al.Oncogene (Basingstoke). 1998, Vol 16, Num 9, pp 1183-1185, issn 0950-9232Article

How is the mutational status for tumor suppressors p53 and p16^INK4A in MFH of the bone?TAUBERT, H; BERGER, D; HINZE, R et al.Cancer letters. 1998, Vol 123, Num 2, pp 147-151, issn 0304-3835Article

Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomasWÜRL, P; TAUBERT, H; MEYE, A et al.Virchows Archiv. 1997, Vol 430, Num 3, pp 221-225, issn 0945-6317Article

Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas : a multivariate analysis of five antibodiesWÜRL, P; TAUBERT, H; MEYE, A et al.Journal of cancer research and clinical oncology. 1997, Vol 123, Num 9, pp 502-508, issn 0171-5216Article

Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumorsWÜRL, P; TAUBERT, H; RATH, F.-W et al.International journal of cancer. 1996, Vol 69, Num 4, pp 317-323, issn 0020-7136Article